The Medicines Patent Pool (MPP) is improving access to high quality affordable medicines and health technologies, particularly in developing countries, through patent pooling and non-exclusive voluntary licensing.
Discover
While reaffirming its work in core areas – HIV, hepatitis C and tuberculosis – MPP has now expanded its mandate to new disease areas including cancer, cardiovascular disease, diabetes and COVID-19.
Children are one of the most vulnerable yet neglected population in terms of access to optimal medicines in adapted formulations. Consequently, paediatric therapies often remain limited and sub-optimal. To address this issue, MPP and partners are accelerating the development and uptake of child-friendly formulations.
Long-acting therapeutics are emerging as gamechangers in healthcare by offering a simpler yet effective way of administering medicines that frees patients from daily pills, helps them stay on treatment & reduces burden on health systems. MPP is working on an access plan to ensure that as these products get developed, they are available to everyone, everywhere and at the same time.
Biotherapeutics like monoclonal antibodies are crucial for treating diseases but remain inaccessible in many low- and middle-income countries. MPP is working on improving access through voluntary licensing, technology transfer, and collaborations with key stakeholders.
MPP supports diversified manufacturing through licensing and facilitating technology transfer to local and regional manufacturers, contributing to improved access to health products, supply security, and emergency preparedness and response.
MPP aims to incorporate licensing and technology transfer as essential elements in the global framework for pandemic preparedness and response.
MPP collaborates closely with key partners to ensure that licensing and funding agreements for early-stage health technologies include terms that facilitate access in low- and middle-income countries.
Technology Transfer is the process of sharing knowledge, skills, scientific and technological developments between two or more parties. This is a resource intensive exercise and can encompass a significant level of complexity, with effectiveness and success hinging on many factors.
The Medicines Patent Pool’s patents and licences database MedsPaL is a free resource that provides information on the intellectual property status of the following key health technologies and products.